Inhibition of transforming growth factor β-activated kinase 1 prevents inflammation-related cartilage degradation in osteoarthritis.
Osteoarthritis (OA) is a common debilitating joint disorder, there's still no available disease-modifying drug for OA currently. This study aims to explore the role of TAK1 in OA pathogenesis and therapeutic efficiency of TAK1 inhibition for OA. The contribution of TAK1 to OA pathogenesis was investigated by intra-articular injection of TAK1-encoding adenovirus in rats. TAK1 inhibitor 5Z-7-induced expression changes of extracellular matrix (ECM)-related genes were detected by real-time PCR. The protective effect of 5Z-7 against OA progression was evaluated in a post-traumatic OA rat model. Our results showed that intra-articular injection of Ad-Tak1 induced cartilage destruction and OA-related cytokine secretion in rat joints. TAK1 inhibition by 5Z-7 efficiently blocked NF-κB, JNK and p38 pathways activation in OA chondrocytes and synoviocytes, Meanwhile, 5Z-7 significantly decreased the expression of matrix-degrading enzymes and pro-inflammatory cytokine, while increased ECM protein expression, which are all crucial components in OA. 5Z-7 also ameliorated ECM loss in OA cartilage explants. More importantly, 5Z-7 significantly protected against cartilage destruction in a rat model of OA. In conclusion, our findings provide the first in vivo evidence that TAK1 contributes to OA by disrupting cartilage homeostasis, thus represents an ideal target for OA treatment, with 5Z-7 as a candidate therapeutic.
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Jin
J
Cheng
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Xiaoqing
X
Hu
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Linghui
L
Dai
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Xin
X
Zhang
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Bo
B
Ren
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Weili
W
Shi
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Zhenlong
Z
Liu
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Xiaoning
X
Duan
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Jiying
J
Zhang
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Xin
X
Fu
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Wenqing
W
Chen
Institute of Sports Medicine, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing 100191, China.
Yingfang
Y
Ao
Arthritis Rheum. 2009 Jul;60(7):2037-45
19565477
FEBS Open Bio. 2015 Jun 06;5:492-501
26110105
Drugs Aging. 2010 Feb 1;27(2):95-115
20104937
Osteoarthritis Cartilage. 2006 Jan;14(1):13-29
16242352
Blood. 2012 Nov 1;120(18):3846-57
22972987
Arthritis Rheum. 2007 Jan;56(1):351-9
17195239
J Rheumatol. 2008 Dec;35(12):2306-12
18925684
Science. 1995 Dec 22;270(5244):2008-11
8533096
Connect Tissue Res. 2010 Dec;51(6):452-8
20604713
Curr Drug Targets. 2010 May;11(5):599-613
20199390
Cell Signal. 2013 Jan;25(1):247-54
22981905
Immunity. 2012 Jan 27;36(1):43-54
22226633
Arthritis Rheum. 2001 Jun;44(6):1237-47
11407681
Osteoarthritis Cartilage. 2006 Jan;14(1):1-2
16242362
Cancer Cell. 2010 May 18;17(5):481-96
20478530
EMBO J. 2009 Jul 22;28(14):2028-41
19536134
Drugs Aging. 2012 May 1;29(5):343-58
22550965
Brain. 2005 Jul;128(Pt 7):1634-41
15817518
Nat Med. 2010 Jun;16(6):641-4
20526316
Int J Biochem Cell Biol. 2013 Nov;45(11):2580-4
24004831
Curr Rheumatol Rep. 2013 May;15(5):323
23516014
Arthritis Rheum. 2001 Jul;44(7):1620-32
11465713
J Immunol. 2008 Jul 15;181(2):1143-52
18606667
Curr Opin Rheumatol. 2015 May;27(3):289-94
25784380
Trends Immunol. 2013 Jul;34(7):307-16
23664135
Apoptosis. 2013 Oct;18(10):1224-34
23700229
Curr Drug Targets. 2007 Feb;8(2):305-13
17305508
Osteoarthritis Cartilage. 2014 Jul;22(7):1036-43
24857975
Osteoarthritis Cartilage. 2006 Sep;14(9):839-48
16730463
Osteoarthritis Cartilage. 2012 Dec;20(12):1484-99
22960092
Biomed Pharmacother. 2006 Feb;60(2):55-61
16459052
Cell Death Differ. 2014 Nov;21(11):1667-76
25146924
Osteoarthritis Cartilage. 2007 Sep;15(9):1061-9
17470400
J Biol Chem. 2008 Feb 22;283(8):4850-65
18065760